FDA.reportPublic FDA data

delgocitinib 20 MG/ML Topical Cream

RxCUI
2721167
RxNorm name
delgocitinib 20 MG/ML Topical Cream
Display name
delgocitinib 20 MG/ML Topical Cream
Full name
delgocitinib 20 MG/ML Topical Cream
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AnzupgoDELGOCITINIBLEO Pharma, Inca59bf36e-6f04-4b47-b385-8040c95f040c2026-07-10Warnings, Adverse reactionsExact identifier
rxcui: 2721167

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a59bf36e-6f04-4b47-b385-8040c95f040cdelgocitinib 2 % Topical Cream [PSN] · delgocitinib 20 MG/ML Topical Cream [SCD] · delgocitinib 2 % Topical Cream [SY]34These highlights do not include all the information needed to use ANZUPGO ® safely and effectively. See full prescribing information for ANZUPGO ® . ANZUPGO ® (delgocitinib) cream, for topical use Initial U.S. Approval: 202520250728